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Abstract 
 Expanded use of Chloroquine and hydroxychloroquine drugs for non-malarial disease 
entities has resulted in prolonged duration of therapy and higher daily dosages leading to 
cumulative doses greater than those used in antimalarial therapy. The aim of the study is to 
evaluate and compare the toxic effects of chloroquine and hydroxychloroquine on different 
organs of albino rats. The study was conducted on 60 normal albino rats divided into 3 
groups, the 1st group is the control group that received only distilled water, the 2nd and the 3rd 
group were given a single daily oral doses equivalent to 1/10th of LD50 chloroquine and 
hydroxychloroquine respectively.  Assessment of liver and kidney functions, and 
histopathological changes in liver, kidney, and heart in different groups was done. The 
chloroquine treated group showed significant elevation of serum glutamic pyruvic 
transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), alkaline 
phosphatase (ALP), total bilirubin (TB), serum creatinine-urea (Cr-U), Creatine Kinase-MB, 
C-reactive protein and Malonic dialdehyde levels as compared to control and 
hydroxychloroquine treated group. The histopathological evaluation showed marked hydropic 
degeneragtion, vascular congestion, interstitial hemorrhage, and necrosis in the liver, kidney 
and heart of chloroquine treated group, while hydroxychloroquine treated group showed mild 
congestion and slight cellular degeneration. Thus, hydroxychloroquine is less toxic and 
physicians should prescribe it better than chloroquine. Chloroquine if prescribed for 
therapeutic uses should be taken for short periods. 
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Introduction 
      Chloroquine was first used as an antimalarial agent. It subsequently played an 
important therapeutic role in various rheumatological diseases, including systemic lupus 
erythematosus (SLE), rheumatoid arthritis (RA), and other inflammatory and dermatologic 
conditions. The use of its analogue, hydroxychloroquine, has largely replaced chloroquine in 
most parts of the world, because of better tolerability at high dosages. Both medications share 
a similarity in their therapeutic and toxicological aspects (Pasadhika and Fishman, 2010).      
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            Expanded use of these drugs for nonmalarial disease entities has resulted in prolonged 
duration of therapy and higher daily dosages leading to cumulative doses greater than those 
used in antimalarial therapy (Rüther  et al ., 2007). Many studies revealed that chloroquine 
has many deleterious effects on many systems. The mechanism of chloroquine toxic effects is 
still unknown, but some studies reported that it may be due to the formation of some 
oxidative metabolites, which raises the production of reactive oxygen species (Al-Jassabi et 
al., 2011).   Chloroquine accumulates especially in the Kupffer cells of the liver with resultant 
lysosomal damage including overloading of the liver lysosomes with non-digestible material, 
and an increase in their size and number (Schneider et al., 1997). The reported accumulation 
of CHQ in lysosomes has an apparent destabilizing effect on lysosomal membranes (Zhao et 
al., 2005).  
      However, Ostensen (2006) and Michaelides et al. (2011)  reported that chloroquine 
and hydroxychloroquine are related drugs with different therapeutic and toxic doses. 
Chloroquine is a safe drug when recommended therapeutic doses are used. Most serious 
toxicity occurs following accidental or intentional overdose. The acute ingestion of 1–1.5 g 
(20 mg/kg) will result in toxicity in an adult, and ingestion of 5 g is potentially lethal (Riou et 
al., 1988). Hydroxychloroquine was reported to be less toxic than chloroquine; there are no 
available data on adverse effects of hydroxychloroquine on male fertility (Ostensen , 2006). 
According to animal studies, chloroquine is 2–3 times more toxic than hydroxychloroquine 
(Smith and Klein-Schwartz, 2005). 
     
Aim of the work 
    The aim of this work is to evaluate and compare the toxicological effects of chronic 
exposure to chloroquine and hydroxychloroquine for 6 weeks on adult albino rats. 
 
Material and methods 
 Drugs: Commercial tablets of chloroquine phosphate (Alexoquine 250 mg tablets) was 
purchased from Alexandria Company, and Commercial tablets of hydroxychloroquine 
phosphate (Plaquenil  200-mg film-coated tablets) was purchased from Sanofi Aventis 
Company. 
 
Animals and Experimental design 
   A total of 60 normal adult albino rats of either sex weighing between 180 gm and 220 gm 
were used in this study. Animals were divided randomly into 3 groups with 20 animals in 
each group: 
1. Group 1: Control group, treated with distilled water.  
2. Group 2: Chloroquine treated group, treated with chloroquine.  
3. Group 3: Hydroxychloroquine treated group, treated with hydroxychloroquine.  
      According to the Research Ethics Committee , Faculty of Medicine, University 
of Benha, the rats were maintained under standard housing laboratory conditions. Rats were 
housed in clean well ventilated cages, 12 h light/dark cycles, every 5 rats were housed in a 
separate cage under strict care and hygiene to keep them in normal and healthy conditions. 
Free access to food and water were allowed. The animals were kept under supervision of a 
professional technician. The animals were anesthetized by ether before taking the samples 
and were eliminated by incineration in Benha university hospital incinerator. 
      Both tested drugs were dissolved in distilled water as the two drugs are well soluble 
in water which is an inert substance without any known toxic effects. Each rat received 1/10th 
of the LD50 orally of each drug daily for 6 weeks. Chloroquine median lethal dose (LD50) in 
rats is 330mg/kg (crouzette et al., 1983), while the oral LD50 of hydroxychloroquine in rats is 
1240 mg/kg  (MSDS, 2008). The dose adjusted every week according to the animal’s body 
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weight. The time of drug administration was fixed for all animals at 12 p.m. and the animals 
were fasted 4 hours before drug administration.   The total experimental period was 
designated to be 7 weeks; 6 weeks for drug administration and one week period of passive 
preliminaries in order to acclimatize prior to treatment.  
 
Biochemical estimations 
      At the end of the 6th week, rats were anaesthetized by ether; blood samples  (3 ml) 
from all groups were drawn from the heart of rats by 5 ml syringes. Serum was separated by 
centrifugation at 2500 rpm for 15 min and used for the determination of serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamic pyruvate transaminase (SGPT), alkaline 
phosphatase 
(ALP), total bilirubin (TB), serum creatinine-urea (Cr-U). Also, creatine kinase, c-reactive 
protein and malonic dialdehyde were determined.  
 
Histopathological studies 
  The rats from all groups were sacrificed after ether anesthesia. Tissues were taken 
from the kidney, liver and heart for histological assessment. Formalin fixed, paraffin 
embedded blocks were prepared and 5 microns serial sections were cut and stained with 
haematoxyline and eosin and examined by light microscope (Benli et al, 2008).  
  
Scoring of histopathological lesions 
 Five slides were observed from each organ to evaluate the lesion semi-quantitatively 
by ranking tissue lesion severity (Benli et al, 2008). Ranking was done from 0 to 3 depending 
on the degree and extent of the alteration as follows: no histopathology changes: (0), 
histopathological changes in < 20% of fields: (1+), histopathological changes in 20 to 60% of 
fields: (2+), histopathology changes in >60% of fields: (3+).  
 
Statistical analysis methods 
 All data were analyzed statistically, using a current SPSS statistical package Version 
19 and the data presented as Mean ± Standard Deviation of Means (S.E.M). Comparison 
between two groups was performed using t-test and p value was considered statistically 
significant if ≤ 0.05, P value >0.05 insignificant. 
Results:  
Table 1: Effects of chloroquine and hydroxychloroquine on rat serum biochemical parameters. 
Group 
Biochemical parameters 
SGO
T 
(IU/I) 
SGPT 
(IU/L
) 
ALP 
(IU/L
) 
TB 
(mg/dl
) 
Creatinin
e 
(μmoL/L
) 
Urea 
(mg/dL
) 
Creatin
e 
Kinase-
MB 
(ng/mL
) 
C-
reactiv
e 
protein 
(mg/L) 
Malonic 
dialdehyd
e 
(μmol/L) 
Control group 
42.89 
± 
17.86 
41.66 
± 
25.11 
271 
± 
44.22 
0.78 
± 0.22 
0.41 
± 1.66 
8.01 
± 0.14 
0.9 
± 0.23 
0.3 
± 0.01 0.4 ± 0.12 
Chloroquine  
group 
422.9 
± 
38.12
* 
407.3
1 
± 
35.5* 
362 
± 
34.01 
1.44 
± 0.30 
3.54 
± 0.41* 
15.88 
± 0.21* 
10.06 
± 2.1* 
6.4 
± 1.1* 
4.1 
± 1.02* 
Hydroxychloroqui
ne group 
143.8 
± 
50.23
* 
210.5
2 
± 
515.4
* 
312 
±37.3 
1.02 
± 0.09 
2.31 
± 0.22* 
13.57 
± 0.31 
6.17 
± 0.9* 
4.3 
± 0.8* 
3.9 
± 0.9* 
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Table 2: Histopathological scoring showing effects of chloroquine compared to hydrochloroquine. on rat 
organs. 
Histopathological changes 
Group 
Control group Chloroquine  group Hydroxychloroquine group 
Liver -   
Hepatoportal and Sinusoidal 
congestion - +++ + 
Cloudy swelling and Hydropic 
degeneration - +++ +\- 
Cellular necrosis (Nuclear 
pyknosis, karyorrhexis, karyolysis) - +++ - 
Inflammatory cellular infiltrate - +++ + 
Kidneys  
Vascular congestion - +++ + 
Cloudy swelling and hydropic 
degeneration - +++ +\- 
Inflammation - +++ + 
Interstitial and tubular 
hemorrhage - +++ + 
hyper -cellularity of glomeruli - +++ - 
Focal tubular necrosis - ++ + 
Heart  
Vascular congestion - ++ ++ 
Cloudy swelling of Cardiac muscle 
and loss of striation - +++ + 
Hemorrhage - ++ + 
Cardiac muscle necrosis - ++ - 
Interstitial fibrosis - ++ - 
 
Histopatgological changes 
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Discussion 
     Most antimalarial agents had been shown to be toxic. Chloroquine was first used as an 
antimalarial agent. It subsequently played an important therapeutic role in various 
rheumatological diseases. The use of chloroquine analogue, hydroxychloroquine, has largely 
replaced chloroquine in most parts of the world, because of better tolerability at high dosages 
(Adeeko and Dada, 1998; Pasadhika and Fishman, 2010).  
 So, physicians uses chloroquine and hydroxychloroquine by large doses  in treating 
various rheumatological diseases. Systemic side effects of hydroxychloroquine and 
chloroquine include disturbances in hepatic and renal function (Lee, 2005; Ling Ngan 
Wong, 2008). 
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     The results of the present study indicated that Chloroquine  induced marked lesions in 
the liver,  kidney, and heart, as shown by pathologic study. The lesions appeared on the form 
of hydropic degeneragtion, congestion, inflammation, necrosis and atrophied glomeruli.     
Hydroxychloroquine treated group showed mild changes in organ structure as compared to 
chloroquine group.   Chloroquine produced statistically significant increase  in the level of 
biochemical parameters as compared to control group and hydroxychloroquine treated rats.  
  The histopathologic changes are in agreement with the biochemical results. The 
pathological changes of kidney, liver and heart in rats treated by chloroquine are more severe 
than that occurred with the rats treated with hydrochloroquine. Chloroquine seems to have 
toxic effect as a powerful membrane destabilizer, as well as direct effect on organs (Riou et 
al., 1988). 
      The results of the present study showed that chloroquine has deleterious effects on the 
structure of the liver; 90% of chloroquine treated rats had severe inflammation and congestion 
and this result was statistically significant as compared with control group, only 20% of 
hydroxychloroquine treated rats have  Inflammation and congestion and this results was 
statistically significant.  
         Colombo and Bertini (1988) argued that the biological and pharmacological actions 
of chloroquine are directly related to its interaction with lysosomal membranes. Chloroquine, 
however, decreases the density of hepatocyte lysosomes. this could result from the fact that 
hepatocyte lysosomes accumulate Chloroquine to high extent in the liver.  
        In the present study chloroquine treated rats showed severe hyper -cellularity of 
glomeruli   in 50 % of rats and this result was statistically significant as compared with 
control group and hydroxychloroquine group, while in hydroxychloroquine treated rats only 
10% of treated rats had abnormalities in glomeruli.  
 The accumulation of Chloroquine in tissues may result from inhibition of anti-malarial 
microsomal metabolism in kidney cells and potentiate its uptake in lysosomes in the 
cytoplasm. Chloroquine, which is also deposited in the adrenal glands may indirectly affect 
kidney function by modulating the secretory patterns of aldosterone to cause a reduction in 
tubular Na+ handling. The deposition of CHQ in the epithelial cells of the kidney may result 
in a possible interference with ion movements (Cooper and Magwere, 2008). 
       Currently, there are only few investigations on the effect of Chloroquine on kidney 
morphology. Chloroquine may exert its renal effects indirectly via histopathological and 
ultrastructural cardiac damage through reductions in glomerular filtration rate (Teixeira et 
al., 2002). 
      The results of the present study indicated that short term chronic administration of 
chloroquine can cause necrosis of cells of rats’ organs, hydroxychloroquine treated rats also 
showed these changes but to lesser extent than chloroquine group.  The results of the present 
study revealed that 70% of chloroquine treated rats had interstitial tissue fibrosis compared to 
only 20 % of hydroxychloquine group and this difference was statistically significant. These 
results are agreed with  Jordan et al. (1999) who reported that chloroquine is 2-3 times more 
toxic than hydroxychloroquine in animal studies.  
      Bercovici (1982) in a review of published cases found that chloroquine leads to 
increase the accumulation of cell associated epidermal growth factor (EGF) and inhibition of 
mitogenic activity of EGF and may lead to interstitial fibrosis. 
 These findings in the study agreed with the work of Izunya et al. (2011) who found 
that chronic oral administration of chloroquine may cause cytoplasmic vacuolation, nuclear 
enlargement and apoptosis of cells.       
      Chloroquine is 60% bound to plasma proteins and equally cleared by the kidney and 
liver, the toxicity of chloroquine is partially related to its transiently high whole blood 
concentration presents early in the distribution phase (Looareesuwan et al., 1986). 
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      For biochemical myocardial parameters profile, Creatinine kinase-MB, C-reactive 
protein and Malonic dialdehyde were significantly elevated in the chloroquine treated group 
compared to control. Also, these differences were statistically significant in comparison to 
hydroxychloquine treated group. The increased cardiac markers could be directed to the 
reported pathological degeneration and necrosis in the myocardium. Chloroquine treated rats 
showed moderate congestion and interstitial fibrosis of cardiac muscle. Comparison between 
the two tested drugs showed that chloroquine has more toxic effect on heart than 
hydroxychloroquine,  as 85%  of chloroquine treated rats had fibrosis compared to only 10% 
in hydroxychloroquine treated group. This result was statistically significant.  
      Death from chloroquine toxicity seems to be related to cardiac toxicity from 
chloroquine’s action on the cardiac conduction system and myocardium. (Clemessy et al., 
1995). Long-term chloroquine can cause cardiac complications, such as conduction disorders 
and cardiomyopathy (restrictive or hypertrophic), by structural alteration of the 
interventricular septum (Cervera et al., 2001). 
 
Conclusion 
 In conclusion, the risk of toxicity with chloroquine appears to be significantly higher  
than with hydroxychloroquine. For this reason, chloroquine should only be considered if 
hydroxychloroquine has failed to control the disease adequately. It is recommended that all 
patients taking chloroquine should be counseled on the risk of liver, kidney and heart toxicity 
and examination for renal and liver function should be arranged. The maximum dosage of 
hydroxychloroquine should not exceed 6.5mg / kg body weight (typically 200-400 mg daily). 
 
Recommendations 
      Hydroxychloroquine is lesser toxic than chloroquine to a great extent. So 
hydroxychloroquine must replace chloroquine. Also, liver and kidney function should be 
done periodically for patients receiving hydroxychloroquine and chloroquine for prolonged 
time. Further investigation on the toxicity of chloroquine and hydroxychloroquine should be 
done. Finally, results will be disseminated to rheumatology department in faculties of 
medicine. 
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